title: Should all diabetic patients be treated with a statin?
authors.affiliation: Bert W. Strassburger Lipid Center, Chaim Sheba Medical Center, Tel Hashomer, Israel. yehuda.kamari@sheba.health.gov.il
authors.forename: Yehuda
authors.initials: Y
authors.lastname: Kamari
authors.forename: Rafael
authors.initials: R
authors.lastname: Bitzur
authors.forename: Hofit
authors.initials: H
authors.lastname: Cohen
authors.forename: Aviv
authors.initials: A
authors.lastname: Shaish
authors.forename: Dror
authors.initials: D
authors.lastname: Harats
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000453:epidemiology; D003925:Diabetic Angiopathies / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D015995:Prevalence; D018570:Risk Assessment
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents